Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluocinolone acetonide 0.1% in oral lichen planus: salivary lactoferrin and Candida before and after 3 months
TCTR20200723002Completed
- Sponsor
- Faculty of Dentistry, Chulalongkorn University
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluocinolone in oral lichen planus (OLP), sponsored by Faculty of Dentistry, Chulalongkorn University. Primary endpoint: Salivary lactoferrin. Started Sep 2017; status: completed.
02
Drugs
fluocinolone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on TCTR20200723002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200723002.